Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
(2019) In The New England journal of medicine 381(16). p.1595-1596
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/9c577070-100c-4b7e-9d2b-5626d376ccd8
- author
- Andréasson, Kristofer LU ; Wuttge, Dirk M. LU and Wollheim, Frank A. LU
- organization
- publishing date
- 2019-10-17
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The New England journal of medicine
- volume
- 381
- issue
- 16
- pages
- 2 pages
- publisher
- Massachusetts Medical Society
- external identifiers
-
- pmid:31618555
- scopus:85073461801
- ISSN
- 0028-4793
- DOI
- 10.1056/NEJMc1910735
- language
- English
- LU publication?
- yes
- id
- 9c577070-100c-4b7e-9d2b-5626d376ccd8
- date added to LUP
- 2019-10-25 12:36:28
- date last changed
- 2023-05-01 04:00:34
@article{9c577070-100c-4b7e-9d2b-5626d376ccd8,
author = {{Andréasson, Kristofer and Wuttge, Dirk M. and Wollheim, Frank A.}},
issn = {{0028-4793}},
language = {{eng}},
month = {{10}},
number = {{16}},
pages = {{1595--1596}},
publisher = {{Massachusetts Medical Society}},
series = {{The New England journal of medicine}},
title = {{Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease}},
url = {{http://dx.doi.org/10.1056/NEJMc1910735}},
doi = {{10.1056/NEJMc1910735}},
volume = {{381}},
year = {{2019}},
}